| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |